Dr. Charles Ryan Discusses Sequencing Prechemotherapy Castration-Resistant Prostate Cancer Therapies

Dr. Charles Ryan Discusses Sequencing Prechemotherapy Castration-Resistant Prostate Cancer Therapies

Dr. Charles Ryan Discusses IMAAGEN Trial Update for Prostate Cancer

Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC

Targeted Oncology

Dr. Charles J. Ryan on Patients with mCRPC Treated with Abiraterone

January 8, 2019 - Charles Ryan, MD

Masonic Cancer Center, University of Minnesota

Dr. Charles Ryan Discusses Neoadjuvant Abiraterone Acetate

Dr. Charles Ryan on the COU-AA-302 Abiraterone Acetate Interim Analysis Results

Drs. Charles Ryan and Alicia Morgans talk about: Metastatic Castration-Resistant Prostate Cancer.

Prostate Cancer Information Group

Dr. Ryan on Bone-Targeting Agents for Patients With Prostate Cancer

Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment

Dr. Twardowski on Sequencing Therapies for Patients With mCRPC

Prostate Education Series- Dr. Charles Ryan and Dr. Alicia Morgans

CSC Greater Cincinnati & Northern Kentucky

Dr. Ryan on Prescribing Preferences in Prostate Cancer and RCC

Treatment sequencing for metastatic castration-resistant prostate cancer

Dr. Ryan Discusses the Unblinding of the COU-AA-302 Trial

Dr. Shore on Therapy Combination and Sequencing in Castration-Resistant Prostate Cancer

Clinical Trial Challenges in Metastatic CRPC

Clinical Trials in Non-Metastatic CRPC

Castration Resistant Prostate Cancer: How Do We Sequence Multiple Therapies in Prostate Cancer?

Prostate Conditions Education Council

Dr. Lawrence Karsh on Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer